Ticker > Company >

Nath Bio-Genes share price

Nath Bio-Genes (India) Ltd.

NSE: NATHBIOGEN BSE: 537291 SECTOR: Agriculture  53k   140   10

172.05
-3.40 (-1.94%)
BSE: 21 Nov 04:00 PM

Price Summary

Today's High

₹ 175.65

Today's Low

₹ 171.35

52 Week High

₹ 264.5

52 Week Low

₹ 167.5

FinStar

Ownership Below Par
Stock price may face volatility due to ownership structure.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsWeak
Watch out! The company might not be able to sustain any adverse condition.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

326.96 Cr.

Enterprise Value

359.77 Cr.

No. of Shares

1.9 Cr.

P/E

7.6

P/B

0.51

Face Value

₹ 10

Div. Yield

1.16 %

Book Value (TTM)

₹  338.52

CASH

75.5 Cr.

DEBT

108.31 Cr.

Promoter Holding

45.6 %

EPS (TTM)

₹  22.62

Sales Growth

10.4%

ROE

6.79 %

ROCE

7.34%

Profit Growth

14.25 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year10.4%
3 Year2.65%
5 Year7.57%

Profit Growth

1 Year14.25%
3 Year-10.3%
5 Year0.89%

ROE%

1 Year6.79%
3 Year0.48%
5 Year4.08%

ROCE %

1 Year7.34%
3 Year2.21%
5 Year5.13%

Debt/Equity

0.1774

Price to Cash Flow

4.38

Interest Cover Ratio

5.5819

CFO/PAT (5 Yr. Avg.)

1.23283868129944

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Sep 2024 45.60 16.38
Jun 2024 45.60 16.38
Mar 2024 45.60 16.38
Dec 2023 45.60 16.38
Sep 2023 45.60 16.38
Investors List
* Figures given above are % of equity capital

 Strengths

  • Company’s PEG ratio is 0.53358055454506.
  • Company has a healthy liquidity position with current ratio of 2.1816.
  • The company has a good cash flow management; CFO/PAT stands at 1.23283868129944.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 14.2798918188194.

 Limitations

  • The company has shown a poor profit growth of -10.2968625172508% for the Past 3 years.
  • The company has shown a poor revenue growth of 2.64575743028816% for the Past 3 years.
  • Company has a poor ROE of 0.478215138438066% over the past 3 years.
  • Company has a poor ROCE of 2.21046365150228% over the past 3 years
  • Tax rate is low at 4.62.

Quarterly Result (All Figures in Cr.)

PARTICULARS Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
Net Sales 22.57 31.74 43.04 243.88 32.19
Total Expenditure 17.48 25.95 38.56 206.82 25.63
Operating Profit 5.09 5.78 4.48 37.06 6.56
Other Income 0.06 0.04 0.44 0.14 0.07
Interest 2.44 2.84 1.06 2.24 2.94
Depreciation 0.76 0.76 0.98 0.83 0.83
Exceptional Items 0 2.5 0 0 0
Profit Before Tax 1.96 4.72 2.87 34.13 2.86
Tax 0.35 0.77 0.62 0.25 -0.03
Profit After Tax 1.61 3.96 2.26 33.89 2.89
Adjusted EPS (Rs) 0.85 2.08 1.19 17.83 1.52

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 279.89 307.56 278.36 301.29 332.62
Total Expenditure 225.1 240.8 241.09 252.16 282.15
Operating Profit 54.79 66.76 37.27 49.13 50.48
Other Income 1.82 1.67 1.85 0.56 0.65
Interest 6.65 8.87 10.64 10.36 9.19
Depreciation 1.45 2.82 3.08 3.01 3.26
Exceptional Items 0 0 -88.78 0 3.45
Profit Before Tax 48.51 56.75 -63.39 36.32 42.12
Tax -1.98 1.09 3.95 1.15 1.95
Net Profit 50.48 55.66 -67.34 35.17 40.18
Adjusted EPS (Rs.) 26.57 29.29 -35.43 18.5 21.14

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 19 19 19 19 19
Total Reserves 538.61 594.27 522.97 554.35 591.65
Borrowings 0.3 0.65 0.66 0.4 2.83
Other N/C liabilities 1.72 2.57 2.61 2.79 3
Current liabilities 169.62 173 194.29 216.43 260.6
Total Liabilities 729.25 789.51 739.54 792.97 877.08
Assets
Net Block 246.03 246.93 244.89 244.38 249.45
Capital WIP 0 0 0 0 0
Intangible WIP 0 0 0 0 0
Investments 5 5.05 5.06 5.06 6.06
Loans & Advances 5.89 1.44 21.79 23.54 53.05
Other N/C Assets 0 0 0 0 0
Current Assets 472.33 536.1 467.8 519.99 568.52
Total Assets 729.25 789.51 739.54 792.97 877.08
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations 48.51 56.75 -63.39 36.32 42.12
Adjustment 6.99 9.79 102.29 12.93 10.27
Changes in Assets & Liabilities -44.5 -65.13 -18.97 -9.97 22.67
Tax Paid -1.52 -0.3 -2.88 -0.92 -0.34
Operating Cash Flow 9.48 1.11 17.05 38.37 74.72
Investing Cash Flow -14.44 -10.28 -19.87 -2.88 -27.4
Financing Cash Flow 5.56 16.4 -22.23 -1.67 -9.81
Net Cash Flow 0.61 7.23 -25.05 33.82 37.52

Corporate Actions

Investors Details

PARTICULARS Sep 2023% Dec 2023% Mar 2024% Jun 2024% Sep 2024%
promoters 45.60 45.60 45.60 45.60 45.60
akash farms llp 7.95 9.59 12.24 12.24 12.24
arati farms private limit... 1.07 1.07 1.07 1.07 1.07
ashu farms llp 10.99 13.68 13.68 13.68 13.68
barkha farms llp - 2.75 2.75 2.75 2.75
emerald seeds private lim... 3.63 3.63 3.63 3.63 3.63
ferry fax farms private l... 1.62 1.62 1.62 1.62 1.62
nath biotechnologies ltd 0.53 0.53 0.53 0.53 0.53
nath industries limited 2.80 2.80 2.80 2.80 2.80
nath royal ltd 2.60 2.60 2.60 2.60 2.60
pithambar farms private l... 1.32 1.32 1.32 1.32 1.32
prabha farms private limi... 0.40 0.40 0.40 0.40 0.40
tingli finvest pvt ltd 2.96 2.96 2.96 2.96 2.96
agri tech india limited 7.87 2.65 - - -
barkha farms private limi... 1.86 - - - -
PARTICULARS Sep 2023% Dec 2023% Mar 2024% Jun 2024% Sep 2024%
investors 54.40 54.40 54.40 54.40 54.40
aditya birla sun life tru... 4.36 4.36 4.36 4.37 4.36
meghal bakulesh shah - - 1.31 1.09 1.09
satpal khattar 2.10 2.10 2.10 2.10 2.10
seetha kumari - - - - 1.60
mayo farms llp 5.72 5.72 5.72 5.72 -
tapovan farms llp 5.18 5.18 5.18 5.18 -
kbs properties private li... 1.62 1.62 - - -

Ratings & Research Reports

Company Presentations

Company News

Nath Bio-Genes - Quaterly Results 23 Oct, 4:31 PM Nath Bio-Genes - Quaterly Results 23 Oct, 4:31 PM Nath Bio-Genes - Quaterly Results 23 Oct, 4:31 PM Nath Bio-Genes (India) submits analyst meet intimation 19 Oct, 2:08 PM Nath Bio-Genes (India) informs about board meeting 17 Oct, 12:12 PM Nath Bio-Genes (India) informs about updates 17 Aug, 3:57 PM Nath Bio-Genes (India) informs about outcome of AGM 17 Aug, 2:18 PM Nath Bio-Genes - Quaterly Results 7 Aug, 3:48 PM Nath Bio-Genes - Quaterly Results 7 Aug, 3:48 PM Nath Bio-Genes - Quaterly Results 7 Aug, 3:48 PM Nath Bio-Genes (India) informs about loss of share certificate 14 Jun, 2:21 PM Nath Bio-Genes - Quaterly Results 8 May, 5:19 PM Nath Bio-Genes - Quaterly Results 8 May, 5:19 PM Nath Bio-Genes - Quaterly Results 8 May, 5:19 PM Nath Bio-Genes (India) informs about compliances-certificate 15 Apr, 2:30 PM Nath Bio-Genes (India) informs about EGM 15 Mar, 2:52 PM Nath Bio-Genes (India) informs about disclosure 22 Feb, 2:21 PM Nath Bio-Genes - Quaterly Results 18 Jan, 6:27 PM Nath Bio-Genes - Quaterly Results 18 Jan, 6:27 PM Nath Bio-Genes (India) informs about disclosure 22 Dec, 10:51 AM Nath Bio-Genes (India) informs about disclosure 12 Dec, 5:13 PM Nath Bio-Genes (India) informs about conference call 21 Oct, 10:33 AM Nath Bio-Genes - Quaterly Results 16 Oct, 6:09 PM Nath Bio-Genes - Quaterly Results 16 Oct, 6:09 PM Nath Bio-Genes - Quaterly Results 10 Aug, 5:41 PM Nath Bio-Genes - Quaterly Results 10 Aug, 5:41 PM Nath Bio-Genes (India) informs about AGM 17 Jun, 3:58 PM Nath Bio-Genes (India) informs about change in date of AGM and book closure 23 May, 2:36 PM Nath Bio-Genes - Quaterly Results 22 Apr, 5:58 PM Nath Bio-Genes - Quaterly Results 22 Apr, 5:58 PM Nath Bio-Genes (India) informs about compliance certificate 17 Apr, 2:36 PM Nath Bio-Genes (India) informs about analyst meet 6 Dec, 3:17 PM Nath Bio-Genes (India) informs about loss of share certificate 24 Nov, 4:27 PM Nath Bio-Genes - Quaterly Results 20 Oct, 3:43 PM Nath Bio-Genes - Quaterly Results 20 Oct, 3:43 PM Nath Bio-Genes - Quaterly Results 20 Oct, 3:43 PM Nath Bio-Genes (India) informs about disclosure 3 Sep, 11:20 AM Nath Bio-Genes (India) informs about disclosure 29 Aug, 4:47 PM Nath Bio-Genes (India) informs about compliance certificate 27 Jul, 11:58 AM Nath Bio-Genes (India) informs about disclosure 24 Jun, 9:51 AM Nath Bio-Genes - Quaterly Results 11 Feb, 4:17 PM Nath Bio-Genes (India) board to approve financial results 4 Feb, 5:09 PM Nath Bio-Genes - Quaterly Results 1 Nov, 4:24 PM Nath Bio-Genes (India) informs about board meeting 25 Oct, 12:58 PM Nath Bio-Genes (India) informs about disclosure 22 Jun, 4:26 PM Nath Bio-Genes (India) informs about compliance certificate’ 20 Apr, 4:35 PM Nath Bio-Genes (India) informs about presentation 12 Feb, 10:36 AM Nath Bio-Genes (India) to hold board meeting 29 Oct, 12:58 PM Nath Bio-Genes (India) informs about virtual meeting 22 Sep, 10:47 AM Nath Bio-Genes (India) informs about outcome of board meeting 15 Jun, 3:34 PM

Nath Bio-Genes Stock Price Analysis and Quick Research Report. Is Nath Bio-Genes an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Nath Bio-Genes stock price today is Rs 172.35. Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Nath Bio-Genes . 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Nath Bio-Genes has a PE ratio of 7.61811728408704 which is low and comparatively undervalued .

  • Share Price: - The current share price of Nath Bio-Genes is Rs 172.35. One can use valuation calculators of ticker to know if Nath Bio-Genes share price is undervalued or overvalued.

  • Return on Assets (ROA): - Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Nath Bio-Genes has ROA of 4.8115 % which is a bad sign for future performance. (higher values are always desirable)

  • Current ratio: - The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Nath Bio-Genes has a Current ratio of 2.1816 .

  • Return on equity: - ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Nath Bio-Genes has a ROE of 6.7866 % .(higher is better)

  • Debt to equity ratio: - It is a good metric to check out the capital structure along with its performance. Nath Bio-Genes has a Debt to Equity ratio of 0.1774 which means that the company has low proportion of debt in its capital.

  • Sales growth: - Nath Bio-Genes has reported revenue growth of 10.3997 % which is poor in relation to its growth and performance. 

  • Operating Margin: - This will tell you about the operational efficiency of the company. The operating margin of Nath Bio-Genes for the current financial year is 15.1749312814525 %.

  • Dividend Yield: - It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Nath Bio-Genes is Rs 2 and the yield is 1.1594 %.

  • Earnings Per Share: - It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Nath Bio-Genes is Rs 22.6237 . The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Nath Bio-Genes in Ticker for free. Also, one can get the intrinsic value of Nath Bio-Genes by using Valuation Calculators, which are available with a Finology ONE subscription. 

Last Updated on:
Brief about Nath Bio-Genes
X